Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206831
Company: EUGIA PHARMA

Products on ANDA 206831

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ISOSULFAN BLUE	ISOSULFAN BLUE	50MG/5ML (10MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 206831

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/02/2016	ORIG-1	Approval		STANDARD	Review (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/206831Orig1s000Approv.pdf

Therapeutic Equivalents for ANDA 206831

ISOSULFAN BLUE

SOLUTION;SUBCUTANEOUS; 50MG/5ML (10MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ISOSULFAN BLUE	ISOSULFAN BLUE	50MG/5ML (10MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	210294	AM REGENT
ISOSULFAN BLUE	ISOSULFAN BLUE	50MG/5ML (10MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206831	EUGIA PHARMA
ISOSULFAN BLUE	ISOSULFAN BLUE	50MG/5ML (10MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	213130	MEITHEAL
ISOSULFAN BLUE	ISOSULFAN BLUE	50MG/5ML (10MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	216090	MSN
ISOSULFAN BLUE	ISOSULFAN BLUE	50MG/5ML (10MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	090874	MYLAN INSTITUTIONAL
ISOSULFAN BLUE	ISOSULFAN BLUE	50MG/5ML (10MG/ML)	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	210558	SOMERSET THERAPS LLC